Thyroid hormone inhibits ERK phosphorylation in pressure overload-induced hypertrophied mouse hearts through a receptor-mediated mechanism

作者: Jorge Suarez , Brian T. Scott , Jorge A. Suarez-Ramirez , Citlalic V. Chavira , Wolfgang H. Dillmann

DOI: 10.1152/AJPCELL.00168.2010

关键词:

摘要: Pressure overload-induced cardiac hypertrophy results in a pathological type of with activation signaling cascades like the extracellular signal-regulated kinase (ERK) pathway, which promotes negative remodeling and decreased contractile function. In contrast, thyroid hormone mediates physiological resulting enhanced addition, action is diminished pressure hypertrophy. We hypothesized that status modulates ERK activity administration could alter this induced by overload. activated phosphorylation; accordingly, we investigated phosphorylation hearts control, hypothyroid, hyperthyroid mice. effect T3 treatment on hypertrophied from transverse aortic-constricted (TAC) mice was investigated. Results showed phosphorylated (p-ERK) 25% hypothyroid presented increased p-ERK 80%. TAC greater than fourfold increase compared control Interestingly, dramatically canceled TAC-induced (36% lower control). Raf-1 upstream pathway. 45% phospho-Raf-1 (Ser338). inhibited overload further p-Raf-1 (Ser338) 37%, control. Overexpression receptor-α cultured cardiomyocytes potentiated inhibitory phosphorylation. concluded has an Raf-1/ERK Furthermore, pathway receptor-dependent mechanism.

参考文章(31)
Tetsuro Wakatsuki, Joseph Schlessinger, Elliot L. Elson, The biochemical response of the heart to hypertension and exercise Trends in Biochemical Sciences. ,vol. 29, pp. 609- 617 ,(2004) , 10.1016/J.TIBS.2004.09.002
C. Pantos, Christodoulos Xinaris, Iordanis Mourouzis, Vassiliki Malliopoulou, Elissavet Kardami, Dennis V. Cokkinos, Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: Potential therapeutic implications in reversing cardiac remodeling? Molecular and Cellular Biochemistry. ,vol. 297, pp. 65- 72 ,(2007) , 10.1007/S11010-006-9323-3
Syed Haq, Gabriel Choukroun, Hae Lim, Kevin M. Tymitz, Federica del Monte, Judith Gwathmey, Luanda Grazette, Ashour Michael, Roger Hajjar, Thomas Force, Jeffery D. Molkentin, Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure Circulation. ,vol. 103, pp. 670- 677 ,(2001) , 10.1161/01.CIR.103.5.670
Constantinos Pantos, Iordanis Mourouzis, Christodoulos Xinaris, Zoi Papadopoulou-Daifoti, Dennis Cokkinos, Thyroid hormone and "cardiac metamorphosis": potential therapeutic implications. Pharmacology & Therapeutics. ,vol. 118, pp. 277- 294 ,(2008) , 10.1016/J.PHARMTHERA.2008.02.011
Paul J. Davis, Jack L. Leonard, Faith B. Davis, Mechanisms of nongenomic actions of thyroid hormone. Frontiers in Neuroendocrinology. ,vol. 29, pp. 211- 218 ,(2008) , 10.1016/J.YFRNE.2007.09.003
MITCHELL A. LAZAR, Thyroid hormone receptors : multiple forms, multiple possibilities Endocrine Reviews. ,vol. 14, pp. 184- 193 ,(1993) , 10.1210/EDRV-14-2-184
Huaping He, Markus Meyer, Jody L. Martin, Patrick M. McDonough, Peter Ho, Xiaojing Lou, Wilbur Y. W. Lew, Randa Hilal-Dandan, Wolfgang H. Dillmann, Effects of Mutant and Antisense RNA of Phospholamban on SR Ca2+-ATPase Activity and Cardiac Myocyte Contractility Circulation. ,vol. 100, pp. 974- 980 ,(1999) , 10.1161/01.CIR.100.9.974
N. H. Purcell, B. J. Wilkins, A. York, M. K. Saba-El-Leil, S. Meloche, J. Robbins, J. D. Molkentin, Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 14074- 14079 ,(2007) , 10.1073/PNAS.0610906104
Wolfgang Dillmann, Cardiac hypertrophy and thyroid hormone signaling Heart Failure Reviews. ,vol. 15, pp. 125- 132 ,(2010) , 10.1007/S10741-008-9125-7
Giovanni Esposito, Sathyamangla V. Naga Prasad, Antonio Rapacciuolo, Lan Mao, Walter J. Koch, Howard A. Rockman, Cardiac Overexpression of a Gq Inhibitor Blocks Induction of Extracellular Signal–Regulated Kinase and c-Jun NH2-Terminal Kinase Activity in In Vivo Pressure Overload Circulation. ,vol. 103, pp. 1453- 1458 ,(2001) , 10.1161/01.CIR.103.10.1453